Engimmune Therapeutics ^None

Engimmune Therapeutics is a company that uses cutting-edge technologies in the life sciences to develop highly potent and specific therapies based on T cell receptors (TCR) targeting solid tumors. They have developed a suite of platform technologies based on genome editing, deep sequencing, and high-throughput functional screening, which enables the engineering of synthetic TCRs that are highly potent and specific to a tumor target. They aim to pave the way for more effective and safer TCR-T cell and soluble TCR therapeutics.